GlobeNewswire

In-Memory Computing Summit Announces Stellar Roster of Keynotes for Second Annual European Conference

Dela

FOSTER CITY, Calif., June  12, 2018  (GLOBE NEWSWIRE) -- GridGain Systems, provider of enterprise-grade in-memory computing platform solutions based on Apache® Ignite(TM), today announced the keynote speakers for the second annual In-Memory Computing Summit Europe, the premier In-Memory Computing (IMC) conference for computing experts from across Europe and Asia, taking place at the Park Plaza Victoria London, June 25-26, 2018. Speakers from ING Belgium, 451 Research, CG Consultancy, FSB Technology, ScaleOut Software, the Storage Networking Industry Association (SNIA) and GridGain Systems will discuss how mature in-memory computing technologies are delivering the speed and scalability necessary for digital transformation, omnichannel customer experience, Big Data and Fast Data use cases.

The In-Memory Computing Summit® Europe 2018 is the only in-memory computing conference focusing on the full range of in-memory computing-related technologies and solutions. Attendees will learn about the role of in-memory computing in the digital transformation of enterprises in the financial services, software, fintech, e-commerce, retail, online business services, healthcare, travel, telecom and other major industries. The conference is attended by technical decision makers, business decision makers, architects, CTOs, developers and more who make or influence purchasing decisions about in-memory computing, Big Data, Fast Data, IoT and HPC solutions.

Keynote Speakers

Monday, June 25

Abe Kleinfeld, President & CEO, GridGain Systems - "In-Memory Computing - Unlocking the Digital Future" - 9:10 a.m. to 9:35 a.m.
All companies, regardless of the industry they serve, are rapidly becoming software companies in their own right, creating a real-time digital twin that virtually models their physical world. The competitive advantage gained by early adopters promises to be transformational and will dramatically improve the market agility of these companies as we progress toward a digital world.

David Follen, Chapter Lead at ING Belgium - "Embracing the Service Consumption Shift in Banking" - 9:35 a.m. to 10:00 a.m.
Legacy banking systems are not tailored for the drastic shift in consumer habits and service consumption. This keynote will look at how ING uses in-memory computing platforms to ensure a smooth transition for its customers.

Sam Lawrence, Co-founder and CTO, FSB Technology (UK) Ltd. - "In-Memory Computing and Sports Betting" - 10:00 a.m. to 10:30 a.m.
Competition, innovation, regulation and improved data collection have grown the complexity of Sports Betting systems at an unprecedented rate. Coupled with a massive growth in transaction volumes, Sports Betting provides a great case study for considering the relationship between technological advance and business need. This presentation is a personal look at the technical challenges the industry has faced, the solutions implemented by FSB Tech, and some best guesses of likely crunch points in the future.

Tuesday, June 26

Alex McDonald, Director and Vice Chair at SNIA Europe - "Persistent Memory, NVM Programming Model, and NVDIMMs" - 9:10 a.m. to 9:35 a.m.
The Storage Networking Industry Association (SNIA), its technical work, and its outreach initiatives are key contributors to an ecosystem driving system memory and storage into a single, unified "persistent memory" entity. Learn how the SNIA Non Volatile Memory Technical Work Group is delivering specifications describing the behavior of a common set of software interfaces that provide access to non volatile memory, and how hardware and OSes support persistent memory today.

Matt Aslett, Research Director, 451 Research - "In-Memory Computing: Accelerating the Data Behind Digital Business and the Customer Experience" - 9:35 a.m. to 10:00 a.m.
The need to engage more intelligently in real time during each transaction or interaction, whether it's to add personalization and recommend products or to help improve the overall customer experience across multiple channels, is driving the requirement for new infrastructure with much lower latency and much higher scalability. The solution that many companies have adopted is to move all the transactional and analytic data, and to collocate computing together in memory using in-memory computing technologies.

William Bain, CEO, ScaleOut Software, Chris Goodall, Director, CG Consultancy (UK) Limited, Sam Lawrence, Co-founder and CTO, FSB Technology (UK) Ltd, and Tim Wood, Head, HPC and Model Integration at ING Financial Markets - "In-Memory Computing Driving the Digital Enterprise: A Panel Discussion" - 10:00 a.m. to 10:30 a.m.
A panel of industry experts, including end users and vendors from ING, FSB Technology, CG Consultancy, GridGain Systems and Scaleout Software, will discuss the impact of in-memory computing on the digital enterprise.

Raffle for Complimentary Passes
Enter the weekly raffle for a £20 General Admission Pass. Visit the conference website raffle page now to enter the drawing.

Sponsors
The In-Memory Computing Summit Europe 2018 is sponsored by leading technology vendors. Current sponsors include:

Platinum Sponsor - GridGain Systems
Gold Sponsor - ScaleOut Software
Silver Sponsors - Neeve Research
Association Sponsors - Storage Networking Industry Association (SNIA), Apache Software Foundation
Media Sponsors - Digitalisation World, Enterprise Times, IT for CEOs & CFOs, IT Pro ODBMS.org

"ScaleOut Software is excited to help sponsor the In-Memory Computing Summit, an industry focal point for the fast-growing in-memory computing community," said David Brinker, Chief Operating Officer at ScaleOut Software. "We are looking forward to an engaging exchange of ideas on the latest technical developments and customer use cases. Please stop by our display at the show in London to learn more about our company's in-memory technology for stateful stream processing and data-parallel analytics."

About the In-Memory Computing Summit
The In-Memory Computing Summits in Europe and North America are the only industry-wide events tailored to in-memory computing-related technologies and solutions. They are the perfect opportunity to connect with technical IT decision makers, IT implementers, and developers who make or influence purchasing decisions in the areas of in-memory computing, Big Data, Fast Data, IoT and HPC. Attendees include CEOs, CIOs, CTOs, VPs, IT directors, IT managers, data scientists, senior engineers, senior developers, architects and more. The Summits are unique forums for networking, education and the exchange of ideas - ideas that power the new world and future of Fast Data. For more information, visit https://imcsummit.org and follow the event on Twitter @IMCSummit.

About GridGain® Systems
GridGain Systems is revolutionizing real-time data access and processing by offering an in-memory computing platform built on Apache® Ignite(TM). GridGain solutions are used by global enterprises in financial, software, e-commerce, retail, online business services, healthcare, telecom and other major sectors, with a client list that includes Barclays, ING, Sberbank, Finastra, IHS Markit, Workday, and Huawei. GridGain delivers unprecedented speed and massive scalability to both legacy and greenfield applications. Deployed on a distributed cluster of commodity servers, GridGain software can reside between the application and data layers (RDBMS, NoSQL and Apache® Hadoop®), requiring no rip-and-replace of the existing databases, or it can be deployed as an in-memory transactional SQL database. GridGain is the most comprehensive in-memory computing platform for high-volume ACID transactions, real-time analytics, web-scale applications, continuous learning and HTAP. For more information, visit gridgain.com.

CONTACT:
Terry Erisman
GridGain Systems
terisman@gridgain.com
(650) 241-2281

GridGain and the In-Memory Computing Summit are trademarks or registered trademark of GridGain Systems, Inc. Apache, Apache Hadoop, Hadoop, Apache Ignite, and Ignite are trademarks of The Apache Software Foundation. All other product and company names herein may be trademarks of their registered owners.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: GridGain Systems via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum